Assessing COVID-19 Vaccine Effectiveness

Moderator(s)

• 

  Vin Lo Re, III, MD, MSCE (he/him/his)

  Associate Professor of Medicine and Epidemiology
  University of Pennsylvania
  Philadelphia, United States
• 

  Hilda Duran, MPH, MD, MSc (she/her/hers)

  Scientist
  La Salle University, Mexico

Presentations:

• 8:00 AM – 8:15 AM CEST

  Drug target Mendelian Randomisation vs propensity score weighting for causal inference: estimating vaccine-induced antibody effect on COVID-19 outcomes
  

  Presenting Author: Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford

  Co-Author: Marta Alcalde Herraiz – University of Oxford

  Co-Author: Danielle Newby, PhD – University of Oxford

  Co-Author: Stephen Burgess – MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom

  Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
• 8:15 AM – 8:30 AM CEST

  Added Benefit and Waning Effectiveness of a Third-Dose mRNA COVID-19 Vaccine in Community-Dwelling Medicare Beneficiaries Aged ≥65 Years in Omicron Period
  

  Co-Author: Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration

  Co-Author: Kathryn Matuska, BA – Acumen, LLC

  Presenting Author: Rowan McEvoy, B.S. – Acumen, LLC

  Co-Author: Hector S. Izurieta, MD, PhD – US Food and Drug Administration

  Co-Author: Jessica R. Hervol, MPH – Acumen, LLC

  Co-Author: Mikhail Menis, PharmD, MS (he/him/his) – Center for Biologics Evaluation and Research, Food and Drug Administration

  Co-Author: Arnstein Lindaas, MA – Acumen, LLC

  Co-Author: Whitney Steele, PhD – Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

  Co-Author: Yoganand Chillarige, MPA – Acumen LLC

  Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC

  Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA

  Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
• 8:30 AM – 8:45 AM CEST

  Considerations for Negative Control Outcome Analyses in Vaccine Effectiveness Studies: Post-Hoc Analyses from an Adult Vaccine Effectiveness Study conducted within the FDA BEST Initiative
  

  Presenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology

  Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health

  Co-Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions

  Co-Author: Jie Deng – Optum Epidemiology

  Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health

  Co-Author: Morgan M. Richey, Ph.D, MPH – RTI International

  Co-Author: Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology

  Co-Author: Ron J. Parambi, MBBS, MPH – Optum

  Co-Author: Michael Miller, n/a – Optum Life Sciences

  Co-Author: Jennifer Song, MA, MURP – United Health Group

  Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve

  Co-Author: Lisa B. Weatherby – Optum Epidemiology

  Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute

  Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions

  Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health

  Co-Author: Grace W. Yang – OptumServe

  Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health

  Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
• 8:45 AM – 9:00 AM CEST

  Effectiveness of COVID-19 vaccines administered during pregnancy in Spain and Norway
  

  Presenting Author: Núria Mercadé-Besora, MS – University of Oxford

  Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

  Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

  Co-Author: Berta Raventós, PhD – Erasmus Medical Center

  Co-Author: Theresa Burkard, PhD (she/her/hers) – University of Oxford

  Co-Author: Edward Burn, PhD – University of Oxford

  Co-Author: Martí Català, PhD (he/him/his) – University of Oxford

  Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

  Co-Author: Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

  Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway

  Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
• 9:00 AM – 9:15 AM CEST

  Innovative Self-controlled Risk Interval Analysis of Effectiveness of COVID-19 mRNA Booster Vaccination in the Veterans Health Administration, Omicron Predominant Period
  

  Co-Author: Caroline Korves, ScD – White River Junction Veterans Affairs Medical Center

  Co-Author: Martin Kulldorff, PhD – Acumen, LLC

  Co-Author: Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center

  Co-Author: Jeremy Smith, MPH – White River Junction Veterans Affairs Medical Center

  Co-Author: Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center

  Co-Author: David J. Graham, MD, MPH – US Food and Drug Administration

  Co-Author: Jurandir Dalle Lucca, MD, PhD – White River Junction Veterans Affairs Medical Center

  Presenting Author: Hector S. Izurieta, MD, PhD – US Food and Drug Administration
• 9:15 AM – 9:30 AM CEST

  Effectiveness Over Time of a Complete Primary Series of the Original, Monovalent COVID-19 Vaccines Among Adults Aged 18-64 Years in the United States
  

  Presenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions

  Co-Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology

  Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration

  Co-Author: Yixin Jiao – Acumen, LLC

  Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health

  Co-Author: Jie Deng – Optum Epidemiology

  Co-Author: Joann F. Gruber, PhD, MSPH – US FDA

  Co-Author: Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology

  Co-Author: Ron J. Parambi, MBBS, MPH – Optum

  Co-Author: Michael Miller, n/a – Optum Life Sciences

  Co-Author: Jennifer Song, MA, MURP – United Health Group

  Co-Author: Lisa B. Weatherby – Optum Epidemiology

  Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute

  Co-Author: An-Chi Lo – Acumen, LLC

  Co-Author: Jessica R. Hervol, MPH – Acumen, LLC

  Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC

  Co-Author: Sylvia Cho, PhD – US FDA

  Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration

  Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA

  Co-Author: Christine L. Bui, MPH – RTI-HS

  Co-Author: Alexandra Stone, PhD, MSc – Optum Serve

  Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve

  Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health

  Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA

  Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration

  Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health

  Co-Author: Kandace L. Amend, PhD – Optum Epidemiology

  Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health

  Co-Author: Yoganand Chillarige, MPA – Acumen LLC

  Co-Author: Grace W. Yang – OptumServe

  Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions

  Co-Author: Azadeh Shoaibi, PhD, MHS – FDA